BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36401555)

  • 21. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
    Brandão LR; Shah N; Shah PS
    Cochrane Database Syst Rev; 2014 Mar; (3):CD005982. PubMed ID: 24615288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
    Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen.
    Chen R; Liu X; Law AD; Kanfar S; Maze D; Chan SM; Gupta V; Yee KW; Minden MD; Schimmer AD; Schuh AC; McNamara CJ; Murphy T; Xu A; Falcone U; Seki J; Sibai H
    Curr Oncol; 2020 Dec; 28(1):128-137. PubMed ID: 33704181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboembolism in children with cancer: a retrospective multicenter study in Korea.
    Choi HS; Kim HJ; Kang HJ; Lee JW; Shin HY; Park HJ; Park BK; Lee YH; Lee JA; Lim YJ; Park KD
    J Thromb Thrombolysis; 2019 May; 47(4):558-565. PubMed ID: 30666552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
    Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
    J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials.
    Borchmann S; Müller H; Hude I; Fuchs M; Borchmann P; Engert A
    Ann Oncol; 2019 Aug; 30(8):1329-1334. PubMed ID: 31132094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Perini E; Penholati RR; Carvalho MG
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of thrombotic complications in acute lymphoblastic leukemia.
    Zia AN; Chitlur M
    Indian J Pediatr; 2013 Oct; 80(10):853-62. PubMed ID: 23912824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
    Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
    Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
    Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management.
    Ghanem KM; Dhayni RM; Al-Aridi C; Tarek N; Tamim H; Chan AKC; Saab R; Abboud MR; El-Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study].
    Chinese Children′s Cancer Group Acute Lymphoblastic Leukemia 2015 Study Group
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1002-1010. PubMed ID: 36207846
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
    Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
    Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group.
    Moser O; Zimmermann M; Meyer U; Klapper W; Oschlies I; Schrappe M; Attarbaschi A; Mann G; Niggli F; Spix C; Kontny U; Klingebiel T; Reiter A; Burkhardt B; Woessmann W
    Haematologica; 2021 May; 106(5):1390-1400. PubMed ID: 32299903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis.
    Pelland-Marcotte MC; Tole S; Pechlivanoglou P; Brandão LR
    Thromb Haemost; 2019 Dec; 119(12):2034-2042. PubMed ID: 31600808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
    Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
    Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.
    Murphy BR; Roth M; Kolb EA; Alonzo T; Gerbing R; Wells RJ
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27700. PubMed ID: 30908863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.